The Transformative Growth of the US Acute Myeloid Leukemia Market What is the Size of US Acute Myeloid Leukemia Industry? US Acute Myeloid Leukemia Market is expected to grow at a CAGR of ~ % in 2022 and is expected to reach ~USD Mn by 2028. The US Acute Myeloid Leukemia market is the rapid advancement in precision medicine and targeted therapies. The emergence of… Read More »
Top 3 US Pharmaceutical Companies and Their Strategies in US Acute Myeloid Leukemia Market US Acute Myeloid Leukemia Market is growing due to advancement in treatment approaches, increase healthcare costs and expenditure, growing investments in Research and Development, and a constant growth in population. Story Outline Pfizer Inc.- An American multinational company with the highest annual revenue of around 100 billion US$ in 2022 in the drug market. The… Read More »
Top 5 players in US Biosimilar Market STORY OUTLINE Pfizer: Excelling in the line of Biosimilar drugs with an experience of more than 10 years with presence in over 180 countries. Amgen: Making pharmaceutical products with an experience of over 40 years and presence in over 100 countries. Viartis: Presence in over 165 countries, and making Biosimilar drugs in over 75 markets,… Read More »
The US Axial Spondyloarthritis market is anticipated to reach a ~USD 2.3 Bn. industry by 2028: Ken Research The United States Axial Spondyloarthritis market which currently has a market size of ~USD 1.3 Bn. is projected to grow at a CAGR of ~9.5% in the next five years as per the findings of Ken Research. Story Outline Rising cases of Axial Spondyloarthritis pose as a demand for the correct diagnosis and treatment of… Read More »
The US Biosimilar market is expected to reach ~USD 96 Bn Industry by 2028 The United States Biosimilar market which currently has a market size of ~USD 9.48 Bn. is expected to grow at a CAGR of ~40% in the next five years and become a ~USD 96 Bn. industry as per the findings of Ken Research. STORY OUTLINE Biosimilar drugs tend to be cost effective and this reason… Read More »
US Acute Myeloid Leukemia Market Expected to Reach 1 Billion US$ by 2028 The US Acute Myeloid Leukemia Market is poised for a steered growth due to advancement in treatment approaches, increases healthcare costs and expenditure, growing investments in Research and Development, and a constant growth in population. Story Outline Advancement in treatment approaches such as targeted therapies, checkpoint inhibitors, personalized medicines, and immunotherapies, help to enhance treatment… Read More »
The US Urinary Tract Infection Therapeutics Market is expected to reach ~$2Bn by 2028: Ken Research The US urinary tract infection therapeutics market is anticipated to grow at a CAGR of ~2% and become a ~USD 2Bn industry by 2028. Currently, this industry has a market size of ~USD1.8 Bn. STORY OUTLINE The rising age of the population is one of the major factor responsible for the growth of the US UTI Therapeutics… Read More »
The US Anesthesia Drug market is anticipated to become a ~USD 6.4 Bn Industry by 2028: Ken Research The United States Anesthesia Drug market is predicted to grow at a CAGR of ~4% in the upcoming 5 years as per the findings of Ken Research. STORY OUTLINE Rising surgical procedures in the US are a major factor behind the growth of the US Anesthesia Drug market. Increasing geriatric population typically requires more surgeries… Read More »
The US Cancer Vaccine Market is anticipated to reach ~USD 7 Bn Industry by 2028: Ken Research The US Cancer Vaccine Market is predicted to grow at a CAGR of ~17% which would result in making it an approximately USD 7 Bn industry by 2028 as per the findings of Ken Research. STORY OUTLINE Rising cases of cancer in the USA are a major factor that are accelerating the growth of US… Read More »
The Global Biopharmaceuticals Market was valued at USD 350 Mn Market in 2020 Will the projections justify growth? : Ken Research The market will be growing at the rate of 8% owing to growing R&D scope alongside increasing investment scenario respiratory devices & rising cases of respiratory illnesses, says a report by Ken Research Global Respiratory Devices Market Ecosystem The Global Biopharmaceuticals market is moderately fragmented in nature, with the presence of many international players as… Read More »
